Royalty Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Royalty Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5% to $2,354,554,000. The net income raised on $1,134,834,000 and profit margin reached 48%. Total operating expenses were $862,404,000.
Profit Margin
| 2015 | 1.65B | 581.42M | 35.19% |
|---|---|---|---|
| 2017 | 1.59B | 1.21B | 75.72% |
| 2018 | 1.79B | 1.37B | 76.76% |
| 2019 | 1.81B | 2.34B | 129.45% |
| 2020 | 2.12B | 495.19M | 23.34% |
| 2021 | 2.28B | 478.75M | 20.91% |
| 2022 | 2.23B | 42.83M | 1.91% |
| 2023 | 2.35B | 1.13B | 48.2% |
RPRX Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 2.35B | 2.23B | 2.28B | 2.12B | 1.81B | 1.79B | 1.59B | 1.65B |
Cost of revenue | 560.65M | 5.67M | 22.99M | 88.11M | 1.01B | 135.96M | 33.26M | 0 |
Gross profit | 1.79B | 2.23B | 2.26B | 2.03B | 794.93M | 1.65B | 1.56B | 1.65B |
Operating exp. | ||||||||
Research and development | 52M | 177.10M | 200.08M | 26M | 83.03M | 392.60M | 117.86M | 98.38M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 862.40M | 1.31B | 858.74M | 527M | -808.92M | 430.44M | 658.23M | 789.98M |
Operating income | 1.49B | 977.49M | 1.43B | 1.59B | 2.62B | 1.36B | 939.69M | 794.27M |
Other income (expenses), net | 207.93M | -747.43M | -189.51M | 106.55M | -161.75M | 408.92M | 403.48M | -35.57M |
Income before tax | 1.70B | 230.06M | 1.24B | 1.70B | 2.46B | 1.51B | 1.34B | 758.70M |
Income tax expense | 0 | 187.23M | 762.44M | 1.14B | 349.33M | 433.36M | 542.65M | 177.28M |
Net income | 1.13B | 42.83M | 478.75M | 495.19M | 2.34B | 1.37B | 1.21B | 581.42M |
Earnings per share | ||||||||
Basic EPS | 3.41 | 0.09 | 1.15 | 1.32 | 6.42 | 3.89 | 3.42 | 0.96 |
Diluted EPS | 2.53 | 0.09 | 1.15 | 1.32 | 6.42 | 3.89 | 3.42 | 0.96 |
| Data source | Data source | Data source | Data source |